Baird Financial Group, Inc. Dexcom Inc Transaction History
Baird Financial Group, Inc.
- $59 Billion
- Q3 2025
A detailed history of Baird Financial Group, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 502,336 shares of DXCM stock, worth $29.2 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
502,336
Previous 637,765
21.23%
Holding current value
$29.2 Million
Previous $55.7 Million
39.28%
% of portfolio
0.06%
Previous 0.1%
Shares
24 transactions
Others Institutions Holding DXCM
# of Institutions
1,083Shares Held
377MCall Options Held
6.76MPut Options Held
7.24M-
Vanguard Group Inc Valley Forge, PA49.5MShares$2.87 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$979 Million0.04% of portfolio
-
Baillie Gifford & CO15.9MShares$922 Million0.84% of portfolio
-
Geode Capital Management, LLC Boston, MA11MShares$637 Million0.05% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...